Zydus, Lupin face FDA flag on weight-loss injectable exports

Zydus, Lupin face FDA flag on weight-loss injectable exports — The U.S. FDA issued a warning letter over quality issues in weight-loss injectables exported by Indian firms Zydus and Lupin. This may disrupt shipments and trigger regulatory scrutiny. Shares may face near-term pressure as compliance costs or plant upgrades loom. No patient harm reported, but export delays could impact revenue.

📊 STOCKS: ZYDUSLIFE, LUPIN | 🏢 SECTOR: Pharma | #HIGHIMPACT #FDA